These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3390473)

  • 21. [Thromboplastic and fibrinolytic activity of the tissues of pregnant uterus and the elements of fertilized ovum].
    Vdovina GF; Skipetrov VP; Azbukina LN
    Vopr Okhr Materin Det; 1975 Jun; 20(6):75-9. PubMed ID: 1136329
    [No Abstract]   [Full Text] [Related]  

  • 22. [Animal experiment methods for the testing of fibrinolytic and antifibrinolytic agents].
    Klöcking HP; Markwardt F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 92(1):84-9. PubMed ID: 4189378
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of nafamostat mesilate on coagulation and fibrinolysis in hepatic resection.
    Shimada M; Matsumata T; Shirabe K; Kamakura T; Taketomi A; Sugimachi K
    J Am Coll Surg; 1994 May; 178(5):498-502. PubMed ID: 8167888
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thrombin activatable fibrinolysis inhibitor (TAFI) affects fibrinolysis in a plasminogen activator concentration-dependent manner. Study of seven plasminogen activators in an internal clot lysis model.
    Guimarães AH; Rijken DC
    Thromb Haemost; 2004 Mar; 91(3):473-9. PubMed ID: 14983222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Localized fibrinolysis of the tonsil and antiplasmin compounds].
    Asaga M; Okamoto M; Asaga H; Kimura M
    Nihon Jibiinkoka Gakkai Kaiho; 1971 Feb; 74(2):462-3. PubMed ID: 5106660
    [No Abstract]   [Full Text] [Related]  

  • 26. Influence of dipeptide derivatives of S-substituted cysteines on the time of fibrinolysis.
    Midura-Nowaczek K; Bruzgo I; Roszkowska-Jakimiec W; Worowski K
    Rocz Akad Med Bialymst; 1996; 41(2):412-6. PubMed ID: 9020554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Antifibrinolytic and coagulation inhibiting effect of Contrykal].
    Schulz K; Gülzow M
    Dtsch Gesundheitsw; 1969 Jun; 24(23):1057-60. PubMed ID: 5393838
    [No Abstract]   [Full Text] [Related]  

  • 28. Measurement of fibrinolytic activity after epsilon-aminocaproic acid administration in rats (Rattus norvegicus).
    Gogjian MA; Barry KJ; Stein BM
    Lab Anim Sci; 1981 Dec; 31(6):710-1. PubMed ID: 7343767
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antifibrinolytic activity of epsilon-aminocaproyl derivatives of amino acids.
    Midura-Nowaczek K; Bruzgo I; Dubis E; Roszkowska-Jakimiec W; Worowski K
    Pharmazie; 1996 Oct; 51(10):775-7. PubMed ID: 8941949
    [No Abstract]   [Full Text] [Related]  

  • 30. Bleeding related to disturbed fibrinolysis.
    Kolev K; Longstaff C
    Br J Haematol; 2016 Oct; 175(1):12-23. PubMed ID: 27477022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The influence of low dose heparin in elective surgery on blood coagulation, fibrinolysis, platelet function, antithrombin III and antiplasmin.
    Kruse-Blinkenberg HO; Gormsen J
    Acta Chir Scand; 1980; 146(6):375-82. PubMed ID: 7008475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Blood coagulation and fibrinolysis in venous blood after prophylactic use of antifibrinolytic agents in heart surgery with the use of xtracorporeal circulation].
    Deutschinoff A; Dimitrov D
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 88(2):166-73. PubMed ID: 4174654
    [No Abstract]   [Full Text] [Related]  

  • 33. [On the difference between serum and euglobulin in determination of fibrinolytic activities by streptokinase-activated method with special reference to the relationship with antiplasmin agents].
    Miyatani K; Fukui I
    Rinsho Byori; 1971 Mar; 19(3):223-6. PubMed ID: 4252723
    [No Abstract]   [Full Text] [Related]  

  • 34. About the activation of the coagulation system during on-pump and off-pump coronary surgery and the use of antifibrinolytic drugs.
    Casati V; Guerra F; D'Angelo A
    J Thorac Cardiovasc Surg; 2006 Sep; 132(3):733-4; author reply 734. PubMed ID: 16935164
    [No Abstract]   [Full Text] [Related]  

  • 35. [Fibrinolytic bleedings in urology].
    Lipsky H; Hubmer O
    Z Urol Nephrol; 1969; 62(6):453-61. PubMed ID: 5314209
    [No Abstract]   [Full Text] [Related]  

  • 36. The influence of epsilon-aminocaproic acid derivatives on the anticoagulant activity of heparin.
    Midura-Nowaczek K; Bruzgo I; Worowski K; Roszkowska-Jakimiec W
    Rocz Akad Med Bialymst; 1998; 43():228-31. PubMed ID: 9972059
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Studies on the anticoagulant properties of natural protease inhibitors].
    Schulz K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 88(2):225-35. PubMed ID: 4174663
    [No Abstract]   [Full Text] [Related]  

  • 38. Blood coagulation and fibrinolysis.
    Heimburger N; Trobisch H
    Angew Chem Int Ed Engl; 1971 Feb; 10(2):85-97. PubMed ID: 4995468
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of heparin and AMCA on coagulation and fibrinolysis in blood and lymph following massive haemorrhage in dogs.
    Leandoer L; Bergentz SE; Nilsson IM
    Acta Chir Scand; 1969; 135(1):1-6. PubMed ID: 5805939
    [No Abstract]   [Full Text] [Related]  

  • 40. [Determination of the components of fibrinolytic system].
    Slobozhankina IK
    Lab Delo; 1973; 11():662-4. PubMed ID: 4132568
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.